Abstract: Implantation of left ventricular assist devices typically requires cardiopulmonary bypass support, which is associated with postoperative complications. A novel suture-less inflow cannula, which can be implanted without bypass, uses mild myocardial compression to seal the interface, however, this may lead to necrosis of the myocardium. To circumvent this issue, a bilayered scaffold has been developed to promote tissue growth at the interface between cannula and myocardium. The bilayered scaffold consists of a silicone base layer, which mimics the seal, and a melt electrospun polycaprolactone scaffold to serve as a tissue integration layer. Biocompatibility of the bilayered scaffolds was assessed by analyzing cell viability, morphology, and metabolic activity of human foreskin fibroblasts cultured on the scaffolds for up to 14 days. There was no evidence of cytotoxicity and the cells adhered readily to the bilayered scaffolds, revealing a cell morphology characteristic of fibroblasts, in contrast to the low cell adhesion observed on flat silicone sheets. The rate of cell proliferation on the bilayered scaffolds rose over the 14-day period and was significantly greater than cells seeded on the silicone sheets. This study suggests that melt electrospun bilayered scaffolds have the potential to support tissue integration of a suture-less inflow cannula for cardiovascular applications. Furthermore, the method of fabrication described here and the application of bilayered scaffolds could also have potential uses in a diverse range of biomedical applications.
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Cardiovascular disease is the single largest cause of mortality in the industrialized world, with 17.3 million deaths recorded annually (1) . The increased incidence of heart failure and a shortage in donor hearts has forced clinicians to look for alternative treatment options, one of which is the use of left ventricular assist devices (LVADs). LVADs provide mechanical circulatory support as a bridge to transplant, bridge to recovery, bridge to candidacy, or destination therapy, with over 2000 continuous flow LVAD implantations performed annually in the United States (2) .
LVAD implantation is a lengthy surgical procedure that requires extensive suturing, whereby a sewing ring is usually sutured to the left ventricular apex followed by apical coring and attachment of the LVAD (3). Most patients are placed on cardiopulmonary bypass (CPB) (4, 5) ; however, the use of CPB has been reported to increase the risk of endorgan dysfunction and a high rate of bleeding, one of the most common postoperative complications with continuous flow LVADs (6, 7) . Increased bleeding may be due to hemodilution of clotting factors and device-induced coagulopathies (8) , therefore, improved cannulation techniques may eliminate the need for CPB and improve patient doi: 10.1111/aor.13018 outcomes (9) . There is a growing interest in developing suture-less cannulae to reduce surgical time and allow off-bypass LVAD implantation, a procedure that would greatly benefit patients by reducing blood loss, shortening hospital stay, reducing costs, and minimizing the risk of end-organ dysfunction (9, 10) A number of suture-less inflow cannulation techniques have already been described. For instance, Koenig et al. (10) developed the suture-less beating heart LVAD connector system where myocardial connection is achieved via a conical spring, which is inserted into the myocardium and attached to a fitting that suits clinically available LVAD cannulae. An equally novel device has been developed by Cohn (11) , who used compression of the myocardium to seal the cannula interface. The device is implanted through a complex series of sheaths, struts, and internal parts that collapse several radially expanding arms which create an internal ventricular seal.
A suture-less cannula has also been developed by our group (12) which uses radially expanding arms and myocardial compression. This design allows the device to be implanted in a few rapid steps and has the capacity to improve ventricular flow dynamics, potentially minimizing thrombus formation via its flared internal geometry (13, 14) .
The suture-less cannula includes an internal, removable coring device which, when retracted, collapses the internal components to form an inner flange that seals the myocardium against an external flange (Fig. 1) prior to LVAD attachment. The radially expanding struts are covered in silicone to allow expansion, creating a full radial seal to prevent blood from entering the internal side of the struts. However, due to the mild compression of the myocardium, tissue necrosis may occur. To prevent catastrophic device failure resulting from tissue necrosis, a layer of tissue is required to integrate from the apical endocardium onto the flanged silicone section of the cannula. Silicone on its own is extremely hydrophobic and provides low adhesiveness for cell attachment, which limits the capacity for tissue integration (15) . A novel method that promotes tissue integration is needed, particularly one that also minimizes thromboembolic events (16, 17) .
Polymeric scaffolds, which can stretch with the silicone seal while providing a suitable environment for tissue growth, may be used to encourage tissue integration. Such scaffolds can be created by a technique known as melt electrospinning, a method that is widely used to fabricate scaffolds for a range of tissue engineering applications (18, 19) . Melt electrospinning has benefits over conventional solution electrospinning in regards to superior fiber deposition precision, allowing for tailored scaffold characteristics, and excludes solvent related toxicity issues (20) . In brief, melt electrospinning works on the principle of melting a polymer, typically achieved alongside a syringe pump to provide a consistent flow rate of polymer through a needle tip. High voltage creates an electrostatic potential on the polymer, forming a Taylor Cone (21) . A jet is ejected from the tip of the Taylor Cone which produces micro/nano fibers which hit the collector, a platform on which the scaffold is built, forming nonwoven highly porous structures with a large surface area beneficial for cell growth (22) . Rapid cooling of the polymeric jet due to the high surface area causes the fiber to solidify during flight, or shortly after landing on the collector. Melt electrospinning can, therefore, result in submicron fibers down to approximately 800 nm (compared to 100-500 mm with conventional 3D printing) which are beneficial for cell growth due the high surface to volume ratio (19, 23) .
A bilayered scaffold consisting of a silicone base layer and tissue integration scaffold upper layer may be suitable for the suture-less cannula. However, integration of such a scaffold with a silicone cover, as exists on the suture-less cannula, is challenging since adhesives may influence the scaffold structure and tissue growth. To our knowledge, there have been no reports which investigate the feasibility of a bilayered scaffold consisting of silicone and melt electrospun scaffolds, especially with the interest in establishing tissue integration of a novel suture-less inflow cannula design. As a result, aims of this study were (i) to fabricate novel bilayered scaffolds using melt electrospinning to incorporate polycaprolactone (PCL) fibers directly onto the surface of the silicone seal, and (ii) to assess cell adhesion with the bilayered scaffold using cultured human foreskin fibroblasts (HFFs), with flat silicone as a negative control. PCL was chosen as the scaffold material on the strength of its biocompatibility and physicochemical properties (19) . This investigation involved developing a novel melt electrospinning technique to fabricate the bilayered melt electrospun silicone-PCL 3D scaffolds with the application not limited to only the suture-less inflow cannula. The hypothesis to be tested was whether bilayered PCL-silicone scaffolds had better biological properties compared to flat silicone due to a surface structure that was more conducive to cell adhesion.
MATERIALS AND METHODS
Bilayered scaffolds were fabricated with a silicone base layer and a superficial tissue integration scaffold. In vitro biological experiments were conducted using HFFs, comparing the bilayered scaffolds with silicone sheets. Four groups were investigated: (i) a plain untreated silicone sheet (negative control), (ii) sodium hydroxide treated silicone sheet (negative control), (iii) sodium hydroxide treated melt electrospun PCL scaffold (positive control), and (iv) sodium hydroxide treated bilayered scaffold comprising silicone and PCL (experimental group).
Silicone sheet fabrication
A 2D silicone sheet (Soft Translucent Silicone Rubber, RTV-2, Barnes, Brisbane, Queensland, Australia) was made with 10% diluent (Barnes, Brisbane, Queensland, Australia) by weight. The two-part silicone and diluent were thoroughly mixed prior to the silicone mixture being placed in a vacuum chamber (Labec, VO3, Marrickville Australia and pump JAVAC, JL-2.5, Rowville, Victoria Australia) for 15 min to remove air bubbles. Molding of the plain silicone sheet was made on a flat rectangular acrylic mold (10 3 10 3 3 mm 3 ). Sheets were left to cure for 24 h at room temperature.
Melt electrospinning PCL-only scaffold
Melt electrospinning was performed as described earlier (24) . In brief, PCL (Capa 6400, Lot 05011, Perstorp UK Limited, Warrington, UK) was heated to 708C in a 2 mL plastic syringe and extruded through a 21-gauge needle at 45 mL/h using a syringe pump (AL-1000, World Precision Instruments, Sarasota, FL USA). The syringe tip and collector were at 7 kV and 27.7 kV, respectively and the tip to collector distance was 15 mm. Linear and rotational speeds were set to 1000 mm/min and approximately 30 rpm, respectively. A 50 ms pause was implemented at each end of the linear translation with a total of 4000 linear translational repetitions. PCL-only scaffolds were produced on a customized steel mandrel with a diameter and length of 15 mm and 50 mm, respectively.
Melt electrospinning bilayered scaffold
Silicone preparation was performed as described in the previous section. A silicone releasing agent (J-Wax, Barnes, Australia) was sprayed onto the mandrel to aid in removal. After degassing the silicone mixture, silicone was poured onto a rotating mandrel (30 rpm) with stops at each end to ensure the silicone did not flow outside the desired electrospinning region before curing. The end stops acted as mold boundaries, creating a 2.5 mm thick silicone base for the bilayered scaffold (Fig. 2) . A flat spatula was used to distribute and remove excess silicone. The bilayered scaffold was made using the same melt electrospinning parameters as the PCL-only scaffold. After the electrospinning process had been completed, the mandrel was kept rotating for a further 12 h to ensure the silicone had completely cured before removing the bilayered scaffold. The mandrel was the same size as the suture-less inflow cannula, which allowed accurate production of the bilayered scaffold.
Cell culture
HFFs were used to assess cell adherence and proliferation on the bilayered scaffolds. The HFFs were cultured in complete medium (Dulbecco's Modified Eagle's Medium [DMEM, Thermo Fisher Scientific, Scoresby, Victoria, Australia] supplemented with 1% (vol/vol) 100 U/mL penicillin and 100 lg/mL streptomycin [Thermo Fisher Scientific] and 10% (vol/vol) fetal bovine serum (Lonza Australia, Mount Waverley, Australia]) at 378C and 5% CO 2 .
Bilayered scaffold preparation and cell seeding
Eighteen biopsy-punched samples (ø 5 6 mm) were used for each group for each time point (days 1, 7, and 14), with n 5 6 for MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, n 5 3 for unseeded MTT assay control, n 5 3 for live/dead cell staining, n 5 3 for DAPI (4 0 ,6-diamidino-2-phenylindole, dihydrochloride)/phalloidin staining, and n 5 3 for scanning electron microscopy (SEM).
The PCL scaffolds were treated with sodium hydroxide to increase hydrophilicity and promote initial cell attachment by immersing in freshly prepared 5 M NaOH solution at 378C for 1 h (25, 26) . Samples were rinsed with MilliQ water until the pH was neutral.
The scaffolds were sterilized by immersion in 80% (vol/vol) ethanol for 12 h and allowed to dry overnight in a sterile biosafety cabinet, after which they were UV irradiated for 1 h on each surface.
Prior to cell seeding, all samples were immersed in complete medium inside a falcon tube and placed in an ultrasonic bath for 5 min to remove air bubbles within the scaffolds. Samples were then transferred into 96-microwell plate tissue culture plates and incubated at 378C with 5% CO 2 in culture media overnight prior to cell seeding.
The HFFs were seeded at a density of 50 000 cells in 50 mL of culture medium per sample. Samples were incubated for 1 h (378C, 5% CO 2 ) before the same inoculation volume was aspirated from the bottom of the wells and replaced on top of the scaffold to maximize cell attachment. Following a further incubation of 1 h, an additional 150 mL of culture medium was added to each scaffoldcontaining well.
The culture medium was replenished every other day until the respective time-points were reached except for the final 3 days of the 14 days samples, when the medium was replenished daily.
Scaffold analysis

Determination of HFF cell metabolic activity
Cell metabolic activity was assessed using an MTT (Sigma-Aldrich, Oakville, ON, Canada) assay. At each time point (days 1, 7, and 14), six experimental (n 5 6) and three control (n 5 3) samples from each group were transferred into a 48-multiwell plate with 500 mL of fresh medium containing 20 mL of MTT, for a working concentration of 0.19 mg/mL. The samples were incubated for 4 h at 378C, 5% CO 2 , after which the media were aspirated and 100 mL of dimethyl sulfoxide (DMSO, Merck Millipore, Darmstadt, Germany) was added to each well. The plates were covered in aluminum foil and incubated for 10 min at RT on a rocking platform and the DMSO then transferred into a 96-microwell plate and absorbance measured at 450 nm using a Benchmark Plus Multi-well plate Spectrophotometer (Bio-Rad Laboratories, Hercules, CA, USA).
Live/dead staining
Cell viability, following initial cell seeding and subsequent colonization of the scaffolds, was assessed using a LIVE/DEAD Viability assay (Thermo Fisher Scientific) at days 1, 7, and 14. In brief, samples were washed twice with phosphate buffered saline (PBS) prior to incubation at 378C with 5% CO 2 for 5 min in a working solution of PBS with 0.67 mg/mL of fluorescein diacetate and 5 mg/mL of propidium iodide. Samples were transferred into PBS after incubation and fluorescence
Cell morphology
Confocal laser scanning microscopy. Cell attachment and colonization of all samples were assessed by confocal microscopy. Three samples from each time point (1, 7, and 14 days), were fixed in 4% paraformaldehyde for 30 min and stored in PBS at 48C until all samples had been collected. The samples were fluorescently labeled by first rinsing them three times with PBS before the cell membranes were disrupted with 0.2% (vol/vol) Triton-X-100/ PBS solution for 5 min. Samples were then placed in a 0.5% (vol/vol) BSA/PBS solution with 0.8 U/ mL Alexa Fluor Phalloidin (Molecular Probes, Thermo Fisher Scientific) and 5 mg/mL 4,6-diamino-2-phenylindole (DAPI, Molecular Probes, Thermo Fisher Scientific) for 40 min and rinsed three times in PBS. The samples were imaged using a Nikon A1R confocal laser scanning microscope (Nikon Co. Ltd., Tokyo, Japan).
Scanning electron microscopy. Cell morphology was analyzed by SEM. The samples were fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer, washed in buffer and post fixed in 1% osmium tetroxide. Next, the samples were dehydrated through a graded series of ethanol, and subsequently dried in hexamethyldisilazane, after which they were mounted onto aluminum stubs and sputtered coated with gold using the Leica EM SCD005 sputter coater prior to imaging at 10 kV using a FEI Quanta 200 scanning electron microscope (FEI Company, Eindhoven, The Netherlands).
Statistical analysis method
For the MTT assay, three measurements were recorded and averages calculated. The average absorption of the control group was subtracted from the experimental groups. The results were tested for statistically significant differences between groups using a one-way ANOVA with equal variances not assumed using Dunnett's T3 (SPSS statistics 22, SPSS, Armonk, NY USA) (P 0.05).
Fiber diameters and pore sizes of the scaffolds were measured using ImageJ (v1.51). Fifty random fibers and pores were selected from a SEM image to calculate average fiber and pore sizes.
RESULTS
Bilayered scaffold fabrication
For this study, a novel melt electrospinning process was trialed, whereby the PCL fibers were deposited directly onto a spinning mandrel of curing silicone, creating a strong bond between the two substrates. This method resulted in PCL fibers being embedded within the silicone as was observed by SEM analysis (Fig. 3) . At the interface, the PCL fibers can be seen being completely surrounded by silicone. The fiber diameter for the PCL-only and bilayered scaffolds were 20 6 3 mm and 22 6 3 mm, respectively. Pore sizes for the PCL-only and bilayered scaffolds were 213 6 55 mm and 222 6 78 mm, respectively.
Cell viability
The suitability of the bilayered scaffold as a substrate for cells growth and colonization was assessed by live/dead staining. At day 1, there was a 95% cell survival rate across all four treatment groups, indicating minimal cytotoxicity in the initial cell seeding process (Fig. 4a,d,g,j) . There was no significant increase in the percentage of dead cells over the time course; further indication that the combination of a silicone base and PCL fibrous scaffold had no cytotoxic effects on the cells (Fig. 4a-c) . There was a large number of cells on both the NaOH treated and untreated silicone samples ( Fig. 4g-l) .
Morphological analysis-confocal microscopy
The HFF cells can be seen attaching and elongating along the PCL fibers in both the PCL-only scaffolds and bilayered scaffolds on day 1 (Fig. 5a-f) . The HFFs appear to bridge adjacent polymer fibers (Fig. 5d-f ) and by day 14 the cells had reached confluence, completely covering scaffold pores with a continuous cell sheet (Fig. 5c,f) . By contrast, cells seeded on the NaOH treated and untreated silicone had a rounded appearance, unlike the fibroblastlike morphology typical of these cells in vitro (Fig.  5g-l) . It may be noted that cells on the untreated silicone, Fig. 5i , appear similar to those on Fig. 5c ,f due large detached cell sheets forming on the edges of the silicone sample. The apparent larger cell coverage on untreated silicone, Fig. 5i , compared to treated silicone, Fig. 5l , can be attributed to the region of image capture of a large detached cell sheet as previously mentioned. Scanning electron microscopy micrographs should be complementary analyzed for a better overview of cell attachment and morphology.
Morphological analysis-scanning electron microscopy
Cell attachment and morphology was observed by SEM (Fig. 6) . At day 1 postseeding, there was already evidence of cell sheets forming on the bilayered scaffold (Fig. 6a) . These cell sheets continued to expand with cells wrapping around the PCL fibers (Fig. 6b) , bridging the pores by day 14 ( Fig. 6c) . Due to the larger volume of the PCLonly scaffolds, cells were observed to be more distributed throughout the scaffold for the earlier time points (Fig. 6d,e) ; however, fiber wrapping and bridging by cells were similar to that of the bilayered scaffold by day 14 (Fig. 6f) . By contrast, cells on both the treated and untreated silicones sheets were highly distributed and no significant visible changes were observed between day 7 and 14 ( Fig. 7a-d) . With a higher magnification of the cells (Fig. 8a,b) , clear cell sheet detachment was observed on the treated silicone as opposed to uniform spread along and around the PCL fiber of the bilayered scaffold.
MTT assay
Cell metabolic activity, as measured by the relative amount of formazan conversion by the cells, was significantly higher in the bilayered and PCLonly scaffold groups compared with the silicone groups (Fig. 9) . Cell metabolic activity for all groups showed an increasing trend throughout the 14 days, consistent with a greater number of cells across all four groups.
At day 14, there was a statically significant higher metabolic activity in the PCL-only group compared with the bilayered scaffold group (P 5 0.02). There was no statistically significant difference between the bilayered group and untreated silicone group at day 14 (P 5 0.072).
DISCUSSION
In this study, the feasibility of applying melt electrospinning to create a material interface that improves tissue integration with suture-less inflow cannulae was investigated. In order to produce a leak-proof seal with suture-less cannula, a layer of silicone is required. However, evidence suggests that silicone, while commonly used in medical implants, does not promote cell adhesion and tissue integration, and this may lead to tissue necrosis at the interface between the myocardium and cannula (27) . Melt electrospun PCL scaffolds have high biocompatibility and are favorable for cell attachment due to their highly porous structures. It was hypothesized that by incorporating PCL fibers into silicone, it could promote cell attachment, which in turn could improve tissue integration of the cannula seal. A bilayered scaffold was developed to enhance the tissue ingrowth of the silicone seal by embedding a PCL scaffold into a silicone substrate. The significance of this study was as a proof-ofconcept that the bilayered silicone/PCL scaffolds enhanced cell attachment and proliferation and that such a composite material may improve tissue integration of the suture-less inflow cannula.
There was no evidence of cytotoxicity in any of the treatment groups, suggesting the materials used for the bilayered scaffold can be used for in vivo implantation. The bilayered and PCL-only scaffold had a more uniform cell distribution compared to the silicone sheets, and this suggests that cells will preferentially distribute along the PCL fibers. There was a distinct difference in cell morphology between the cells in the silicone groups and PCL/ bilayered scaffold groups. The atypical rounded cell morphology seen on the silicone surfaces was indicative of sub-optimal cell attachment. Conversely, cells in the bilayered scaffold exhibited an elongated morphology, similar to the morphology seen in the PCL-only control group. This elongated spindle-like morphology is consistent with observations found in vivo (28, 29) . These results suggest silicone on its own as a substrate is unsuitable for tissue integration.
The cell metabolic activity in the bilayered and PCL scaffold groups was significantly higher compared with the silicone groups irrespective of treatment, and this can be ascribed to poor cell attachment and proliferation in the silicone groups; similar findings have been reported by Kyle et al. (27) . There were no significant differences between the silicone groups at any time points and this was consistent with poor cell attachment and silicone being impervious to NaOH treatment (30) .
At day 14, there was a statistically significant difference in metabolic activity between the PCL-only and the bilayered scaffolds, a difference that can be attributed to greater surface areas in PCL-only scaffolds which allows more cells to attach. Since the same electrospinning parameters were used to produce both the bilayered and PCL-only scaffolds, it is likely that PCL fibers embedded in the silicone reduced the effective surface area for cells to access. However, at day 14, the difference did not reach statistical significance, due to the large SD in metabolic activity between the bilayered and silicone groups, most likely due to the large scaffold pore size relative to the sample size, a limitation that could be overcome by decreasing the pore size.
Sodium hydroxide treatment/etching increased the hydrophilicity of PCL by increasing surface roughness and exposure of polyester chains, which in turn enhances cell adhesion and has been shown to improve hemocompatibility (25, 31) . Increased hemocompatibility is of paramount importance given that the bilayered scaffold will reside inside the left ventricle. NaOH treatment of the silicone failed to have any significant effect on cell attachment compared to untreated silicone and implies there is no change to the wetting contact angle after NaOH treatment (30). Siddique et al. (32) showed that surface modification of silicone using oxygen plasma-collagen coatings decreased hydrophobicity but did not improve cell attachment. In contrast, when silicone was oxygen plasma treated with (3-aminopropyl) triethoxysilane (APTES), the APTES-collagen surface was able to maintain higher cell counts. This method could be a complimentary treatment option of the silicone substrate of the bilayered scaffolds.
The use of flat and smooth surfaces on inflow cannulae have been reported to cause complications as seen with the DuraHeart device (Terumo Heart, Inc., Ann Arbor, MI, USA), where wedge thrombus formation was reported (33) . The introduction of an autologous neointima by a rough titanium surface on the inflow cannula of the EVAHEART device (Sun Medical Technology Research Corp., Nagano, Japan) minimized wedge thrombus formation (17) . Similarly, the initial inflow cannula design of the HVAD (HeartWare, Framingham, MA) was a highly-polished titanium surface, which resulted in tissue growth encircling the inlet. This tissue growth obstructed flow and created an emboli source and has since been replaced with a partially rough-surfaced inflow cannula (34) . The HeartMate III rotary heart pump (Thoratec Corporation, Pleasanton, CA, USA) is a LVAD in which all surfaces in direct contact with blood are sintered titanium that is reported to promote growth of a biological lining that lowers thromboembolic risk (35) . It is, therefore, likely that a similar biological lining will form on the bilayered scaffold fabricated in this study due to this material's superior cell attachment compared to silicone-only seals. By using the bilayered scaffold on the novel suture-less cannula, wedge thrombus formation could be eliminated and tissue growth can be controlled.
During sample preparation for SEM, we found that silicone expanded considerably in the 1% osmium tetroxide solution. The samples returned to their original size when dry, prior to gold sputter coating. The appearance of the silicone went from white to black, something which has been reported previously (36) ; however, silicone swelling has not been reported elsewhere. This expansion only affected samples with a silicone composition and no visible changes were seen with the PCL fibers.
Cell culture was conducted in a static in vitro environment and therefore physiological stresses caused by myocardial motion could not be evaluated. Future studies would include using a bioreactor that would better mimic physiological flow conditions.
It can be noted that the use of cardiac fibroblasts would have provided a superior representation of in vivo cells; however, other cardiovascular studies have also used HFFs (37, 38) . As a preliminary study, human foreskin fibroblast cells were chosen based on a study in bovines that found that neointimal tissues consisted of a large proportion of fibroblast-like cells (17) . We hypothesize that bilayered scaffolds will attract endothelial cells when exposed to in vivo conditions, since it has been reported that a pseudointimal lining consisting of von Willebrand factor positive endothelial cells forms on the surfaces of LVADs when implanted in human subjects for more than 100 days (39) .
PCL resorbs relatively slowly in vivo-total resorption of homopolymer PCL takes approximately 2-4 years (19) . It may, therefore, not be the ideal material if no anchoring point is designed onto the suture-less inflow cannula. Refining the design of the suture-less inflow cannula to allow nondeforming areas to act as anchoring points for the tissue may be a solution. We hypothesize that cells will attach, proliferate, anchor, and mature at the tissue interface of the suture-less inflow cannula, thereby creating a robust tissue structure before the PCL degrades.
The novel melt electrospinning fabrication method of the bilayered scaffold for tissue integration of silicone can be utilized in other biomedical applications. There is a growing interest for flexible electronics of which a vast majority is wearable technology for biomedical diagnostics, robotic skins, and prosthetic limbs (40, 41) . As a result, some of these flexible wearable devices that are implanted for long-term monitoring of patients can benefit from tissue integration.
CONCLUSION
This study outlines a novel application for melt electrospinning to create a bilayered silicone/PCLbased scaffold which improved cell responses for a suture-less inflow cannula. The bilayered scaffold has the potential to improve tissue integration of suture-less inflow cannulae by providing a better seal. Cell attachment and growth on the bilayered scaffold was greatly enhanced compared to the silicone-only controls. The use of the bilayered silicone/PCL scaffolds on the suture-less inflow cannula has the potential to eliminate tissue necrosis at the site of compression, minimize thrombus formation and restrict tissue growth to prevent inflow obstructions. The method of bilayered scaffold fabrication reported here can be used for other biomedical applications, such as bionics, where tissue integration is essential on a deformable material.
